Terms: = Leukemia AND RECQL4, RecQ4, 9401, ENSG00000160957, RECQ4, RTS
54 results:
1. Engineered CRISPR prime editors with compact, untethered reverse transcriptases.
Grünewald J; Miller BR; Szalay RN; Cabeceiras PK; Woodilla CJ; Holtz EJB; Petri K; Joung JK
Nat Biotechnol; 2023 Mar; 41(3):337-343. PubMed ID: 36163548
[TBL] [Abstract] [Full Text] [Related]
2. Translesion synthesis by AMV, HIV, and MMLVreverse transcriptases using RNA templates containing inosine, guanosine, and their 8-oxo-7,8-dihydropurine derivatives.
Glennon MM; Skinner A; Krutsinger M; Resendiz MJE
PLoS One; 2020; 15(8):e0235102. PubMed ID: 32857764
[TBL] [Abstract] [Full Text] [Related]
3. Fluorescent Tricyclic Cytidine Analogues as Substrates for Retroviral Reverse Transcriptases.
Turner MB; Purse BW
Chempluschem; 2020 May; 85(5):855-865. PubMed ID: 32378814
[TBL] [Abstract] [Full Text] [Related]
4. Enrichment of heterozygous germline
Maciaszek JL; Oak N; Chen W; Hamilton KV; McGee RB; Nuccio R; Mostafavi R; Hines-Dowell S; Harrison L; Taylor L; Gerhardt EL; Ouma A; Edmonson MN; Patel A; Nakitandwe J; Pappo AS; Azzato EM; Shurtleff SA; Ellison DW; Downing JR; Hudson MM; Robison LL; Santana V; Newman S; Zhang J; Wang Z; Wu G; Nichols KE; Kesserwan CA
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31604778
[TBL] [Abstract] [Full Text] [Related]
5. Realgar transforming solution as a novel arsenic agent with a lower risk of cardiotoxicity.
Hai Y; Song P; Wang X; Zhao L; Xie Q; Li J; Li Y; Li H
J Pharmacol Sci; 2019 Jun; 140(2):162-170. PubMed ID: 31285125
[TBL] [Abstract] [Full Text] [Related]
6. Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin-proteasome pathway.
Hai Y; Wang X; Song P; Li JY; Zhao LH; Xie F; Tan XM; Xie QJ; Yu L; Li Y; Wu ZR; Li HY
Arch Pharm Res; 2019 Aug; 42(8):684-694. PubMed ID: 31214877
[TBL] [Abstract] [Full Text] [Related]
7. Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.
Bhatia S; Krieger V; Groll M; Osko JD; Reßing N; Ahlert H; Borkhardt A; Kurz T; Christianson DW; Hauer J; Hansen FK
J Med Chem; 2018 Nov; 61(22):10299-10309. PubMed ID: 30365892
[TBL] [Abstract] [Full Text] [Related]
8. Autophagy enhanced antitumor effect in K562 and K562/ADM cells using realgar transforming solution.
Wang X; Chen B; Zhao L; Zhi D; Hai Y; Song P; Li Y; Xie Q; Inam U; Wu Z; Yu L; Li H
Biomed Pharmacother; 2018 Feb; 98():252-264. PubMed ID: 29272786
[TBL] [Abstract] [Full Text] [Related]
9. No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib.
Pfirrmann M; Evtimova D; Saussele S; Castagnetti F; Cervantes F; Janssen J; Hoffmann VS; Gugliotta G; Hehlmann R; Hochhaus A; Hasford J; Baccarani M
J Cancer Res Clin Oncol; 2017 May; 143(5):843-850. PubMed ID: 28083711
[TBL] [Abstract] [Full Text] [Related]
10. Viral reverse transcriptases.
Menéndez-Arias L; Sebastián-Martín A; Álvarez M
Virus Res; 2017 Apr; 234():153-176. PubMed ID: 28043823
[TBL] [Abstract] [Full Text] [Related]
11. Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.
Maurer C; Langerbeins P; Bahlo J; Cramer P; Fink AM; Pflug N; Engelke A; von Tresckow J; Kovacs G; Stilgenbauer S; Wendtner CM; Müller L; Ritgen M; Seiler T; Fischer K; Hallek M; Eichhorst B
Leukemia; 2016 Oct; 30(10):2019-2025. PubMed ID: 27133817
[TBL] [Abstract] [Full Text] [Related]
12. Osteosarcoma in patients with Rothmund-Thomson syndrome.
Zils K; Klingebiel T; Behnisch W; Mueller HL; Schlegel PG; Fruehwald M; Suttorp M; Simon T; Werner M; Bielack S
Pediatr Hematol Oncol; 2015 Feb; 32(1):32-40. PubMed ID: 25551679
[TBL] [Abstract] [Full Text] [Related]
13. Temperature effects on the fidelity of a thermostable HIV-1 reverse transcriptase.
Álvarez M; Menéndez-Arias L
FEBS J; 2014 Jan; 281(1):342-51. PubMed ID: 24279450
[TBL] [Abstract] [Full Text] [Related]
14. A M-MLV reverse transcriptase with reduced RNaseH activity allows greater sensitivity of gene expression detection in formalin fixed and paraffin embedded prostate cancer samples.
Hagen RM; Rhodes A; Oxley J; Ladomery MR
Exp Mol Pathol; 2013 Aug; 95(1):98-104. PubMed ID: 23739432
[TBL] [Abstract] [Full Text] [Related]
15. New molecular insights into osteosarcoma targeted therapy.
Yang J; Zhang W
Curr Opin Oncol; 2013 Jul; 25(4):398-406. PubMed ID: 23666471
[TBL] [Abstract] [Full Text] [Related]
16. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract] [Full Text] [Related]
17. Substrate variations that affect the nucleic acid clamp activity of reverse transcriptases.
Oz-Gleenberg I; Herzig E; Voronin N; Hizi A
FEBS J; 2012 May; 279(10):1894-903. PubMed ID: 22443410
[TBL] [Abstract] [Full Text] [Related]
18. Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase.
Barrioluengo V; Wang Y; Le Grice SF; Menéndez-Arias L
FEBS J; 2012 Apr; 279(8):1433-44. PubMed ID: 22340433
[TBL] [Abstract] [Full Text] [Related]
19. Template-independent DNA synthesis activity associated with the reverse transcriptase of the long terminal repeat retrotransposon Tf1.
Oz-Gleenberg I; Herzig E; Hizi A
FEBS J; 2012 Jan; 279(1):142-53. PubMed ID: 22035236
[TBL] [Abstract] [Full Text] [Related]
20. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
[TBL] [Abstract] [Full Text] [Related]
[Next]
